Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 31 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for Skin Tumor Diagnosis

Introduction:The skin is the largest organ of the human body. In detail, it can be divided into structures such as the epidermis, dermi...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

I Want All These Antibodies: Selection of Immunohistochemical Antibodies for Mesothelioma

Introduction:There are many types of immunohistochemical antibodies applicable for the differential diagnosis of mesothelioma. Current ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Tumor Talk: The Silent Ovarian Cancer

Introduction:Ovarian cancer is one of the common reproductive organ tumors in women. Its incidence is lower than that of cervical cance...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Detection of Lymph Node Metastatic Malignant Melanoma: SOX10 Specificity Comparable to S100

Introduction:Sentinel lymph node biopsy has become the gold standard for assessing early lymph node metastasis in malignant melanoma, w...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Antibody Release // FH and 2SC Aid in Precise Diagnosis of FH-Deficient Tumors

Introduction:Fumarate hydratase (FH) and 2-succinocysteine (2SC) are high-quality antibodies newly launched by Maixin. So, what are the...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Technical Guide: Performance Validation of Antibodies

Preface:The director emphasizes the importance of quality control and antibody validation every day, but I always have doubts. I don't ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Fifteenth Issue of “Maimai” Pathology Weekly Reading Notes | Immunohistochemical Markers for Diagnosing Female Reproductive Tract Tumors (Part 1)

Preface:Malignant tumors can occur in almost all parts of the female reproductive tract, with cervical cancer being the most common, fo...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Pan-TRK Immunohistochemical Staining Pattern

Introduction:Pan-TRK immunohistochemistry is a practical method for detecting neurotrophic tyrosine receptor kinase (NTRK) gene fusions...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Indicator for Pituitary Adenoma/PitNETs Classification—T-PIT

Introduction:In 2017, the WHO established a clearer classification for primary adenohypophyseal tumors based on their cell line origin ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Surrounded by “Mountains” Are Not Only Basins, But Also Pathologists.

Introduction:It's not only on the operating table where immense mental burdens exist, nor is it only in the emergency room where rapid ...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar